Oncology
IGEA announces exclusive license agreement for Cliniporator® electroporation technology to OncoSec
IGEA has granted the exclusive license for the Cliniporator® electroporation platform to OncoSec Medical Incorporated within the field of use for DNA-based interleukin-12 (IL-12) gene delivery and other immune-modulatory genes.
ESSO Congress 2019
The 39th Congress of ESSO (European Society of Surgical Oncology) will take place from 9 - 11 October 2019 in Rotterdam, The Netherlands.
CIRSE 2019 Congress
IGEA will be exhibiting at the CIRSE 2019 Congress that will be held in Barcelona, Spain from September 7th to 11th 2019.
Two posters on electrochemotherapy at the 10th ECIO. Amsterdam. 8-11 april 2019
Two Scientific Abstract on electrochemotherapy will be presented as electronic posters at the 10th European Conference of Interventional Oncology (ECIO).
First electrochemotherapy, a new ultra-targeted technique, on a liver cancer in France
More precise, more effective, but also less invasive, electrochemotherapy is the latest in tumor removal techniques.